MinorPlant alkaloid (isoquinoline), food supplement×Phospholipid mixture, dietary supplement. A mass OTC «memory drug» and «hepatoprotector» in Russia. Essentiale (Sanofi, essential phospholipids) is a separate regulated medicine, registered by AEMPS and in Russia for NAFLD
Updated · Methodology
Mechanism
Berberine is a plant alkaloid. It is not authorised as a medicine in Spain and is sold as a food supplement, usually at 250–500 mg two or three times a day (LiverTox, NIH). In healthy men, berberine 300 mg three times a day for two weeks inhibited CYP2D6, CYP2C9 and CYP3A4: exposure to midazolam, a CYP3A4 substrate, rose by 40% (Guo et al., 2012). Lecithin is a phospholipid mixture rich in phosphatidylcholine and, in supplements, one of the forms of choline. It is not authorised as a medicine in Spain and is used as a food supplement and a food emulsifier (NIH Office of Dietary Supplements, choline fact sheet). Choline is not known to have any clinically relevant interactions with medications (NIH choline fact sheet). This combination has not been studied, and no interaction mechanism is known.
Symptoms
No symptoms caused by this combination have been described. Berberine's adverse effects are usually mild and transient: nausea, bloating, diarrhoea or constipation. In controlled trials they were no more frequent than with placebo, and no liver injury from berberine has been described (LiverTox, NIH). Very high choline intakes are associated with a fishy body odour, vomiting, heavy sweating and salivation, low blood pressure and liver toxicity (NIH Office of Dietary Supplements, choline fact sheet).
Management
The combination can be used and no dose change is needed. There are no data on an interaction, and no mechanism that would cause one is known (NIH choline fact sheet). Because berberine inhibits CYP2D6, CYP2C9 and CYP3A4, bear in mind that it may raise the levels of other drugs metabolised by these enzymes (Guo et al., 2012). The tolerable upper intake level of choline from food and supplements for adults is 3.5 g a day (NIH Office of Dietary Supplements, choline fact sheet).
Your whole list in one report
Up to 15 drugs: every pair in one table and a PDF report. Your first report is free: we only ask for your email
Add more drugsMedicine list: everything you take in one place →
Sources
- NIH ODS: Choline – Health Professional Fact Sheet (2024)– NIH Office of Dietary Supplements, Choline fact sheet, updated 2024
- European journal of clinical pharmacology: Repeated administration of berberine inhibits cytochromes P450 in humans. (2012)– Repeated administration of berberine inhibits cytochromes P450 in humans.. European journal of clinical pharmacology 2012. PMID 21870106.
- LiverTox NIDDK: Berberine – LiverTox (2020)– LiverTox: Clinical and Research Information on Drug-Induced Liver Injury, NIDDK, Berberine, last update 06.10.2020